Cover Image

Tissue Plasminogen Activator Is Not Involved in Methamphetamine-Induced Neurotoxicity

To investigate the role of tissue plasminogen activator (tPA) in methamphetamine (METH)-induced dopaminergic neurotoxicity, we compared the changes in tyrosine hydroxylase (TH) and dopamine transporter (DAT) levels in the striatum after repetitive treatment of METH at 4 mg/kg among wild-type, tPA-de...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ayumi Fukakusa (Author), Hiroyuki Mizoguchi (Author), Hiroyuki Koike (Author), Toshitaka Nabeshima (Author), Kazuhiro Takuma (Author), Kiyofumi Yamada (Author)
Format:	Book
Published:	Elsevier, 2008-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neuropsychotoxicity of Abused Drugs: Involvement of Matrix Metalloproteinase-2 and -9 and Tissue Inhibitor of Matrix Metalloproteinase-2 in Methamphetamine-Induced Behavioral Sensitization and Reward in Rodents
by: Hiroyuki Mizoguchi, et al.
Published: (2008)

Drug Dependence, Synaptic Plasticity, and Tissue Plasminogen Activator
by: Kiyofumi Yamada, et al.
Published: (2005)

Basic and Translational Research on Proteinase-Activated Receptors: Regulation of Nicotine Reward by the Tissue Plasminogen Activator (tPA) - Plasmin System via Proteinase-Activated Receptor 1
by: Taku Nagai, et al.
Published: (2008)

Rho kinase inhibitors ameliorate cognitive impairment in a male mouse model of methamphetamine-induced schizophrenia
by: Jingzhu Liao, et al.
Published: (2023)

MicroRNAs in Methamphetamine-Induced Neurotoxicity and Addiction
by: Bi Deng, et al.
Published: (2022)

Brain-Derived Neurotrophic Factor/TrkB Signaling in Memory Processes
by: Kiyofumi Yamada, et al.
Published: (2003)

Protective Effect of Sauchinone on Methamphetamine-Induced Neurotoxicity in Mice
by: Eun Young Jang, et al.
Published: (2012)

Amyloid Pathology and Protein Kinase C (PKC): Possible Therapeutics Effects of PKC Activators
by: Ana Olariu, et al.
Published: (2005)

Placental Extract Improves Hippocampal Neuronal Loss and Fear Memory Impairment Resulting From Chronic Restraint Stress in Ovariectomized Mice
by: Kazuhiro Takuma, et al.
Published: (2012)

Thymoquinone abrogates methamphetamine-induced striatal neurotoxicity and hyperlocomotor activity in mice
by: Ali Roohbakhsh, et al.
Published: (2021)

Protective Effects of Isoliquiritigenin Against Methamphetamine-Induced Neurotoxicity in Mice
by: Min Jung Lee, et al.
Published: (2009)

The Roles of Glial Cell Line-Derived Neurotrophic Factor, Tumor Necrosis Factor-α, and an Inducer of These Factors in Drug Dependence
by: Minae Niwa, et al.
Published: (2007)

Current Research on Methamphetamine-Induced Neurotoxicity: Animal Models of Monoamine Disruption
by: Taizo Kita, et al.
Published: (2003)

Effects of Molecular Hydrogen on Methamphetamine-Induced Neurotoxicity and Spatial Memory Impairment
by: Di Wen, et al.
Published: (2019)

Clozapine Prevents a Decrease in Neurogenesis in Mice Repeatedly Treated With Phencyclidine
by: Kenji Maeda, et al.
Published: (2007)

D-Serine Ameliorates Neonatal PolyI:C Treatment-Induced Emotional and Cognitive Impairments in Adult Mice
by: Taku Nagai, et al.
Published: (2012)

A machine learning model that emulates experts' decision making in vancomycin initial dose planning
by: Tetsuo Matsuzaki, et al.
Published: (2022)

Synergistic Effects of Adenosine A2A Antagonist and L-DOPA on Rotational Behaviors in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Mouse Model
by: Takahiro Matsuya, et al.
Published: (2007)

A Zebrafish Model of Neurotoxicity by Binge-Like Methamphetamine Exposure
by: Juliette Bedrossiantz, et al.
Published: (2021)

Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity
by: Shasha Xu, et al.
Published: (2018)

Role of Tissue-Type Plasminogen Activator in Ischemic Stroke
by: Yasuhiro Suzuki
Published: (2010)

Autophagy involves in the mechanism of nano-alumina induced neurotoxicity
by: Lan Zhang, et al.
Published: (2022)

Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction
by: Raczyńska D, et al.
Published: (2015)

Tissue plasminogen activator for a rare case of neonatal empyema
by: A.B. Montgomery, et al.
Published: (2020)

Epigenetic mechanisms involved in methamphetamine addiction
by: Hang Wang, et al.
Published: (2022)

Emergency nurses\' knowledge and adherence to tissue plasminogen activator guidelines for patients with stroke
by: Elnaz Asghari, et al.
Published: (2024)

Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation
by: Célia Seillier, et al.
Published: (2024)

Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator
by: Ong CT, et al.
Published: (2017)

Effects of Prescription Drug Reduction on Quality of Life in Community-Dwelling Patients with Dementia
by: Mikio Sakakibara, et al.
Published: (2015)

Parishin C Attenuates Phencyclidine-Induced Schizophrenia-Like Psychosis in Mice: Involvements of 5-HT1A Receptor
by: Eun-Joo Shin, et al.
Published: (2010)

Evaluation of Children Receiving Tissue Plasminogen Activator Therapy for Thrombosis: Single Center Experience
by: Ahmet Yöntem, et al.
Published: (2021)

Thrombus attached to suture materials successfully thrombolysed with low-dose tissue plasminogen activator
by: Macit Kalçık, et al.
Published: (2014)

Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and Apoptosis in Alzheimer's Disease
by: Kazuhiro Takuma, et al.
Published: (2005)

Methamphetamine use and malnutrition among street-involved youth
by: Montaner Julio SG, et al.
Published: (2010)

Cannabidiol prevents methamphetamine-induced neurotoxicity by modulating dopamine receptor D1-mediated calcium-dependent phosphorylation of methyl-CpG-binding protein 2
by: Baoyu Shen, et al.
Published: (2022)

QiShenYiQi Inhibits Tissue Plasminogen Activator-Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
by: Yang Ye, et al.
Published: (2022)

Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study
by: Yanqiu Chu, et al.
Published: (2022)

Stability of Recombinant Tissue Plasminogen Activator at −30 °C over One Year
by: Abdulmalik Alkatheri
Published: (2013)

Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
by: Veronique Demers-Mathieu, et al.
Published: (2022)

Exposure to Extremely Low Frequency Magnetic Fields Enhances Locomotor Activity via Activation of Dopamine D1-Like Receptors in Mice
by: Eun-Joo Shin, et al.
Published: (2007)